B
Benitec Biopharma Inc.
BNTC · NASDAQ · Healthcare · 431M
Closing price
$8.87
+1.37% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
2.3×
Enterprise value / EBITDAEV/EBITDA
-4.6×
Free cash flow yieldFCF yield
-4.0%
Return on equityROE
-25.7%
Operating margin
—
Net debt / EBITDAbalance-sheet strength
3.5×
Interest coverage
—
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.